BioSyent, Inc. (RX.V)
13.96
-0.04
(-0.29%)
CAD |
TSXV |
May 29, 16:00
BioSyent Total Assets (Quarterly) : 62.49M for March 31, 2026
Total Assets (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Assets (Quarterly) Benchmarks
| HLS Therapeutics, Inc. | 182.94M |
| Bausch Health Cos., Inc. | 34.19B |
| Cipher Pharmaceuticals, Inc. | 213.91M |
| Revive Therapeutics Ltd. | 0.2614M |
| Knight Therapeutics, Inc. | 1.087B |
Total Assets (Quarterly) Related Metrics
| Total Liabilities (Quarterly) | 17.50M |
| Shareholders Equity (Quarterly) | 44.99M |
| Debt to Equity Ratio | 0.1166 |
| Current Ratio | 1.891 |
| Net Debt Paydown Yield | -0.51% |